@article{6e947b9a101c4b1ca1c145e4e82739ff,
title = "Should pregnant women be included in phase IV clinical drug trials?",
keywords = "birth defects, developmental toxicity, drugs, phase IV clinical trials, pregnancy",
author = "Briggs, {Gerald G.} and Polifka, {Janine E.} and Wisner, {Katherine L.} and Eric Gervais and Miller, {Richard K.} and Anick Berard and Gideon Koren and Alicia Forinash and Towers, {Craig V.}",
note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",
year = "2015",
doi = "10.1016/j.ajog.2015.05.047",
language = "English",
volume = "213",
pages = "810--815",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
number = "6",
}